Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial.
The outcomes of Central Nervous System (CNS) relapses in children with acute lymphoblastic leukaemia (ALL) treated in the ALL R3 trial, between January 2003 and March 2011 were analysed. Patients were risk stratified, to receive a matched donor allogeneic transplant or fractionated cranial irradiati...
Main Authors: | Ashish Narayan Masurekar, Catriona A Parker, Milensu Shanyinde, Anthony V Moorman, Jeremy P Hancock, Rosemary Sutton, Philip J Ancliff, Mary Morgan, Nicholas J Goulden, Chris Fraser, Peter M Hoogerbrugge, Tamas Revesz, Philip J Darbyshire, Shekhar Krishnan, Sharon B Love, Vaskar Saha |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4184796?pdf=render |
Similar Items
-
Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial.
by: Masurekar, A, et al.
Published: (2014) -
Evolving strategies in the management of relapsed acute lymphoblastic leukaemia – TMCKidsALLR1
by: Prakriti Roy, et al.
Published: (2017-01-01) -
Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MIRD) clearance in childhood lymphoblastic leukaemia (ALL)
by: Moorman, A, et al.
Published: (2008) -
Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia
by: O'Connor, D, et al.
Published: (2017) -
PCR-based MRD testing for acute lymphoblastic leukaemia in India
by: Rubina Islam, et al.
Published: (2017-01-01)